Pharma Tech

Dren Bio raises $350m for dibotatug clinical development

Oct 30, 2026, 9:28 AM

Read Full Article → Dren Bio raises $350m for dibotatug clinical development

Translate article text

Choose a language and wait for the translated text.

Dren Bio has secured $350m in an oversubscribed private financing round to advance its primary investigational therapy, dibotatug, through late-stage clinical evaluation, regulatory submission, and potential commercialisation.